title: Comment on the letter by Messori et al. (European Journal of Neurology 2013; 20: e131).
authors.affiliation: Department of Health Sciences, University of Genoa, Genoa, Italy.
authors.forename: M P
authors.initials: MP
authors.lastname: Sormani
mesh_terms: D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020528:Multiple Sclerosis, Chronic Progressive / Q000188:drug therapy*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*
chemical_list: D007155:Immunologic Factors; D007166:Immunosuppressive Agents
keywords: demyelinating diseases; multiple sclerosis; neurological disorders